Selected Major Trials from 2019
  • COMPLETE (Complete Versus Culprit-Only Revascularization Strategies to Treat Multivessel Disease After Early PCI for STEMI)
  • ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches)
  • TWILIGHT (Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention)
  • AUGUSTUS ACS (A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome)
  • COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation)
  • EXCEL (Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization)
  • SYNTAXES (Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery Extended Survival Study)
  • National Cardiogenic Shock Initiative Update
  • Society for Cardiovascular Angiography and Interventions Clinical Expert Consensus Statement on the Classification of Cardiogenic Shock
  • PARTNER 3 (Placement of Aortic Transcatheter Valves 3)